Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» darapladib
darapladib
Update on Glaxo's Darapladib
Yahoo/Zacks
Sat, 05/17/14 - 09:53 am
GSK
darapladib
GlaxoSmithKline's blockbuster dreams dashed as darapladib goes 0-for-2 in PhIII
Fierce Biotech
Tue, 05/13/14 - 10:26 pm
GSK
darapladib
Tale Of Two Heart Drugs Show Challenges And Rewards In R&D
Forbes
Wed, 04/9/14 - 08:51 am
LCZ696
Novartis
heart failure
darapladib
R&D
heart disease
GSK
Glaxo's Utter Stinkbomb Of A Drug
Forbes
Mon, 03/31/14 - 11:44 am
GSK
darapladib
GSK CEO says success of heart drug 'an open question'
Yahoo/Reuters
Mon, 03/31/14 - 09:35 am
GSK
Pharma CEOs
darapladib
Andrew Witty
heart attack
Glaxo’s Darapladib Fails to Prevent Heart Attacks in Test
Bloomberg
Tue, 11/12/13 - 09:53 am
GSK
darapladib
heart attacks
Crunch time for GlaxoSmithKline's big heart drug bet
Yahoo/Reuters
Mon, 11/11/13 - 10:45 am
GSK
darapladib
Glaxo’s Drug Approvals Boost Morale as China Probe Drags
Bloomberg
Thu, 09/12/13 - 10:27 am
GSK
China
darapladib
MAGE-A3
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wed, 08/29/12 - 12:21 pm
Big Pharma
Lipitor
Anacetrapib
Merck
Plavix
Pfizer
Bristol-Myers Squibb
PCSK9 inhibitor
Sanofi
Regeneron
darapladib
Roche
GSK
HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail
Seeking Alpha
Sat, 04/14/12 - 12:19 pm
Human Genome Sciences
albiglutide
darapladib
Emergent BioSolutions
diabetes
Biogen Idec
lupus
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Seeking Alpha
Sun, 06/27/10 - 11:04 am
Anthera
A-002
acute coronary syndrome
GSK
darapladib
Glaxo's Radical Heart Drug
Forbes
Mon, 05/17/10 - 10:32 am
GSK
darapladib
Study sharpens focus on Glaxo's heart drug hope
Reuters
Fri, 04/30/10 - 08:24 am
GSK
darapladib
Glaxo places big bet on drug for clogged arteries
Reuters
Thu, 12/18/08 - 09:27 am
GSK
darapladib